OpenBilldrug price receipt

NADAC week of 2026-10-14

NIKKI 3 MG-0.02 MG TABLET

FDA nonproprietary name: drospirenone and ethinyl estradiol

For 1 unit (EA)

Pharmacies pay

$0.19 filed

1 × $0.1909 per EA

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D paid

$0.65 filed

1 × $0.64858 per EA, Part D average

Medicare's price is not your price.

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18


The spread

3.4× estimated

Medicare paid 3.4× what pharmacies pay.

Part D averages every strength and form sold under “Nikki” / “Ethinyl Estradiol/Drospirenone” into one figure, so it is not specific to this NDC.

OpenBill calculation · DSD_PTD_RY26_P04_V10_DY24_BGM.csv + nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17) · Part D 2024-01-01 to 2024-12-31 (file of 2026-06-25, retrieved 2026-10-18)

Cost-plus estimate

$5.22 estimated

$0.19 + $0.03 (15%) + $5.00 fee per fill = $5.22

This is a model, not a price any pharmacy quoted. Shipping is not included. For a pack this cheap, the $5.00 fee is most of the estimate. How it is worked out

OpenBill calculation · nadac-national-average-drug-acquisition-cost-20261014.csv · NADAC eff. 2026-09-23 (file of 2026-10-14, retrieved 2026-10-17)

Open the interactive card Change the quantity, type what you were charged, and see every record in full.

What it is

NIKKI 3 MG-0.02 MG TABLET is how the CMS NADAC file names this product. The FDA NDC Directory lists it as drospirenone and ethinyl estradiol, under the trade name “Nikki”.

FDA gives its dosage form as kit.

The labeler, the company named on the label, is Lupin Pharmaceuticals, Inc.

FDA lists no Established Pharmacologic Class for it.

The NADAC file of 2026-10-14 prices it under 2 NDCs (National Drug Codes); the FDA directory lists 1 of them.

NADAC classes it as a generic drug (rate-setting class G), and does not mark it as sold over the counter.

What pharmacies pay

Pharmacies pay $0.19 for 1 unit (EA) (1 × $0.1909 per EA, rounded to the cent), by the CMS NADAC file of 2026-10-14; that price took effect on 2026-09-23. That is what pharmacies pay their suppliers, not what they charge you.

NADAC’s explanation code for it: 1, calculated from the most recently completed pharmacy survey.

All 2 NDCs

Other strengths, forms and brands

9 other products in the NADAC file share the FDA nonproprietary name drospirenone and ethinyl estradiol with NIKKI 3 MG-0.02 MG TABLET.

ProductPharmacies pay per unitMedicare per unit
DROSPIRENONE-EE 3-0.02 MG TAB
generic · kit
$0.1909 per EA filed
eff. 2026-09-23
$0.66048 per EA filed
Part D 2024 average
DROSPIRENONE-EE 3-0.03 MG TAB
generic · kit
$0.15106 per EA filed
eff. 2026-09-23
$0.66048 per EA filed
Part D 2024 average
JASMIEL 3 MG-0.02 MG TABLET
generic · kit
$0.1909 per EA filed
eff. 2026-09-23
$0.61702 per EA filed
Part D 2024 average
LO-ZUMANDIMINE 3 MG-0.02 MG TB
generic · kit
$0.1909 per EA filed
eff. 2026-09-23
$0.66502 per EA filed
Part D 2024 average
NIKKI 3 MG-0.02 MG TABLET this page
generic · kit
$0.1909 per EA filed
eff. 2026-09-23
$0.64858 per EA filed
Part D 2024 average
SYEDA 28 TABLET
generic · kit
$0.15106 per EA filed
eff. 2026-09-23
$0.70807 per EA filed
Part D 2024 average
VESTURA 3 MG-0.02 MG TABLET
generic · kit
$0.1909 per EA filed
eff. 2026-09-23
$0.54491 per EA filed
Part D 2024 average
YASMIN 28 TABLET
brand · kit
$4.39715 per EA filed
eff. 2026-09-23
$4.59877 per EA filed
Part D 2024 average
YAZ 28 TABLET
brand · kit
$5.84382 per EA filed
eff. 2026-09-23
$5.89113 per EA filed
Part D 2024 average
ZUMANDIMINE 3 MG-0.03 MG TAB
generic · kit
$0.15106 per EA filed
eff. 2026-09-23
$0.59384 per EA filed
Part D 2024 average

Part D is one average per brand and generic name, over every strength and form.

CMS NADAC · nadac-national-average-drug-acquisition-cost-20261014.csv · eff. 2026-09-23 · as of 2026-10-14 · retrieved 2026-10-17

Medicare Part D · DSD_PTD_RY26_P04_V10_DY24_BGM.csv · eff. 2024-01-01 to 2024-12-31 · as of 2026-06-25 · retrieved 2026-10-18

What Medicare paid

Medicare Part D paid $0.65 for 1 unit (EA), at an average of $0.64858 per EA in 2024 (2024-01-01 to 2024-12-31) for “Nikki” and “Ethinyl Estradiol/Drospirenone”, every strength and form sold under that name together (Medicare Part D Spending by Drug, file of 2026-06-25).

That average covers 3,369 Part D claims (fills, including refills) for 2024-01-01 to 2024-12-31, across every maker, strength and form under the name.

Medicare's price is not your price.

What to ask at the counter

None of these figures is your price: what you pay depends on your pharmacy, your insurance, coupons and discounts.

Questions

Why is the comparison with Medicare for NIKKI 3 MG-0.02 MG TABLET labelled estimated?
Beyond what the card shows, the records give these reasons: The Part D figure covers 2024-01-01 to 2024-12-31; the NADAC price is from the file of 2026-10-14. Part D spending basis, as the Part D record states it: Part D 2024 average spend per dosage unit for Nikki / Ethinyl Estradiol/Drospirenone: all makers, strengths, forms and routes combined, claim-weighted; gross cost incl. dispensing fees and patient pay, before rebates. Unit taken as NADAC's EA. Joined on brand name.
Why does this page start at 1 unit (EA)?
NADAC prices this product per EA, and the FDA NDC Directory lists 1 of its 2 NDCs (it does not list the other one) as dosage form “KIT” with no route. Only a tablet, capsule, lozenge or troche with route “ORAL”, or a tablet or film with route “SUBLINGUAL” or “BUCCAL”, starts at 30, and this is not one. NADAC’s EA for it may be the whole kit or one item in it, and the files do not say which. So the card starts at 1 unit (EA) rather than guess how many make up a fill; change it to match your prescription.